Immunology primer - 01/09/11
Doi : 10.1016/S0889-8529(01)00016-0
David T Robles, BS a, George S Eisenbarth, MD, PhD b, c, ⁎ 
a Medical Scientist Training Program, Department of Immunology, University of Colorado Health Sciences Center, Box B140, 4200 East 9th Ave., Denver, CO 80262, USA
b Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center Box B140, 4200 East 9th Ave., Denver, CO 80262, USA
c Department of Immunology and Pediatrics, University of Colorado Health Sciences Center Box B140, 4200 East 9th Ave., Denver, CO 80262, USA
Corresponding author. Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center Box B140, 4200 East 9th Ave., Denver, CO 80262, USAPlan
 | This work was supported in part by grants from the Childrens Diabetes Foundation, American Diabetes Association, the National Institutes of Health (DK32083, DK55969, AI 39213), Autoimmunity Center of Excellence U19AI46374, Diabetes Endocrine Research Center P30DK57516, and Clinical Research Centers at Childrens (RR0009) and University Hospital (RR00051). |
© 2002
Elsevier Science (USA). Tous droits réservés.
Vol 31 - N° 2
P. 261-282 - juin 2002 Retour au numéro
Article précédent
- Autoimmune polyendocrine syndromes
- George S. Eisenbarth
- Neonatal syndromes of polyendocrinopathy
- Francesco Dotta, Francesco Vendrame
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?